FGFR2 and female reproductive organ cancer: Fibroblast growth factor receptors (FGFR) are a family of transmembrane proteins with tyrosine kinase domains, which are commonly mutated or fused in urothelial, breast, and gynecologic cancers, as well as cholangiocarcinomas (commonly FGFR2) [12].